Cancer Genomics - Proteomics: 4 (3)

May-June 2007; Volume 4,Issue 3

You have access
Editorial
ANGELIKA M. BURGER and BRIAN LEYLAND-JONES

Cancer Genomics & Proteomics May 2007, 4 (3) 107;
You have access
An Exploration into Study Design for Biomarker Identification: Issues and Recommendations
JACQUELINE A. HALL, ROBERT BROWN and JIM PAUL

Cancer Genomics & Proteomics May 2007, 4 (3) 111-119;
You have access
Contribution of DNA and Tissue Microarray Technology to the Identification and Validation of Biomarkers and Personalised Medicine in Breast Cancer
DONAL J. BRENNAN, CATHERINE KELLY, ELTON REXHEPAJ, PETER A. DERVAN, MICHAEL J. DUFFY and WILLIAM M. GALLAGHER

Cancer Genomics & Proteomics May 2007, 4 (3) 121-134;
You have access
Application of Array-based Genomic and Epigenomic Technologies to Unraveling the Heterogeneous Nature of Breast Tumors: On the Road to Individualized Treatment
MARK ABRAMOVITZ and BRIAN LEYLAND-JONES

Cancer Genomics & Proteomics May 2007, 4 (3) 135-145;
You have access
Individualization of Therapy Using Mammaprint®ì: from Development to the MINDACT Trial
STELLA MOOK, LAURA J. VAN'T VEER, EMIEL J.T. RUTGERS, MARTINE J. PICCART-GEBHART and FATIMA CARDOSO

Cancer Genomics & Proteomics May 2007, 4 (3) 147-155;
You have access
Development of Reverse Phase Protein Microarrays for Clinical Applications and Patient-tailored Therapy
RUNA SPEER, JULIA WULFKUHLE, VIRGINIA ESPINA, ROBYN AURAJO, KIRSTEN H. EDMISTON, LANCE A. LIOTTA and EMANUEL F. PETRICOIN

Cancer Genomics & Proteomics May 2007, 4 (3) 157-164;
You have access
Cancer Stem Cells and Individualized Therapy
SARANYA CHUMSRI, PORNIMA PHATAK, MARTIN J. EDELMAN, NAZANIN KHAKPOUR, ANNE W. HAMBURGER and ANGELIKA M. BURGER

Cancer Genomics & Proteomics May 2007, 4 (3) 165-174;
You have access
Tailoring Targeted Therapy to Individual Patients: Lessons to be Learnt from the Development of Mitomycin C
MILÈNE VOLPATO and ROGER M. PHILLIPS

Cancer Genomics & Proteomics May 2007, 4 (3) 175-186;
You have access
Gene Signature-based Prediction of Tumor Response to Cyclophosphamide
ANDRÉ KORRAT, THOMAS GREINER, MARTINA MAURER, THOMAS METZ and HEINZ-HERBERT FIEBIG

Cancer Genomics & Proteomics May 2007, 4 (3) 187-195;
You have access
Gene Signatures Developed from Patient Tumor Explants Grown in Nude Mice to Predict Tumor Response to 11 Cytotoxic Drugs
HEINZ-HERBERT FIEBIG, JULIA SCHÜLER, NIKO BAUSCH, MICHAEL HOFMANN, THOMAS METZ and ANDRE KORRAT

Cancer Genomics & Proteomics May 2007, 4 (3) 197-209;
You have access
Molecular Targets in Metastasis: Lessons from Genomic Approaches
BARBARA FINGLETON

Cancer Genomics & Proteomics May 2007, 4 (3) 211-221;
You have access
Molecular Analysis of Xenograft Models of Human Cancer Cachexia - Possibilities for Therapeutic Intervention
AXEL J. BAUMGARTEN, HEINZ-HERBERT FIEBIG and ANGELIKA M. BURGER

Cancer Genomics & Proteomics May 2007, 4 (3) 223-231;
You have access
Post-transcriptional Control of the MCT-1-associated Protein DENR/DRP by RNA-binding Protein AUF1
KRYSTYNA MAZAN-MAMCZARZ and RONALD B. GARTENHAUS

Cancer Genomics & Proteomics May 2007, 4 (3) 233-239;
You have access
Drug Transporters as Targets for Cancer Chemotherapy
TAKEO NAKANISHI

Cancer Genomics & Proteomics May 2007, 4 (3) 241-254;

Main menu

User menu

Search

Table of Contents

In this issue